Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Catino

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
European Journal of Gynaecological Oncology|January 1, 1992
Prognostic factors in epithelial ovarian cancerG Gargano, A Catino, M Correale, et al.
Tumori|May 6, 1999
Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancerV Lorusso, S Mancarella, A Catino, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1993
Serum and cytosolic levels of CA549 in breast cancer patientsM Correale, I Abbate, C D Dragone, et al.
International Journal of Oncology|May 6, 2011
Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)V Lorusso, F Carpagnano, G Dirienzo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II studyM De Lena, V Lorusso, A Latorre, et al.
Journal of Cellular and Molecular Medicine|April 24, 2008
VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous modelR Patruno, N Arpaia, C D Gadaleta, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2015
miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcomeD Petriella, S De Summa, R Lacalamita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinumM De Lena, V Lorusso, C Bottalico, et al.
British Journal of Cancer|February 20, 2003
Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancerV Lorusso, E Crucitta, N Silvestris, et al.
The International Journal of Biochemistry & Cell Biology|June 9, 2016
Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: A reviewA Daniele, I Abbate, C Oakley, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
European Journal of Gynaecological Oncology|January 1, 1992
Prognostic factors in epithelial ovarian cancerG Gargano, A Catino, M Correale, et al.
Tumori|May 6, 1999
Mitoxantrone, L-leucovorin and 5-fluorouracil: an effective and well tolerated first-line treatment for advanced breast cancerV Lorusso, S Mancarella, A Catino, et al.
Clinical and Experimental Obstetrics & Gynecology|January 1, 1993
Serum and cytosolic levels of CA549 in breast cancer patientsM Correale, I Abbate, C D Dragone, et al.
International Journal of Oncology|May 6, 2011
Accelerated neoadjuvant chemotherapy of non-small cell lung cancer (NSCLC)V Lorusso, F Carpagnano, G Dirienzo, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 2001
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II studyM De Lena, V Lorusso, A Latorre, et al.
Journal of Cellular and Molecular Medicine|April 24, 2008
VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous modelR Patruno, N Arpaia, C D Gadaleta, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 15, 2015
miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcomeD Petriella, S De Summa, R Lacalamita, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 1997
Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinumM De Lena, V Lorusso, C Bottalico, et al.
British Journal of Cancer|February 20, 2003
Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancerV Lorusso, E Crucitta, N Silvestris, et al.
The International Journal of Biochemistry & Cell Biology|June 9, 2016
Clinical and prognostic role of matrix metalloproteinase-2, -9 and their inhibitors in breast cancer and liver diseases: A reviewA Daniele, I Abbate, C Oakley, et al.
Pageof 4